Journals / Toraks Dergisi / 2000 / Cilt: 1 - Sayı: 1

A questionnaire study investigating the knowledge and behaviour by physicians about use of nebuliser

Nebülizatör kullanımı konusunda hekimlerin bilgi ve tutumlarını araştıran bir anket çalışması

Pages
67–71
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In determination of device's effectiveness, functional parameters such as forced expiratory volume in one second and peak expiratory flow rate were being used as a current criterion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In the last years, it has been started to gain more importance that using drug via inhalation in the therapy of respiratory diseases.
📊
Key Findings & Data:It was asked for that 121 physicians, including 65 specialist (53.7%) and 56 resident (46.3%), to answer a questionaire form including 16 questions.
💡
Conclusion & Impact:In determination of device's effectiveness, functional parameters such as forced expiratory volume in one second and peak expiratory flow rate were being used as a current criterion.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Bilgi · Tavırlar · Pratik

Abstract

In the last years, it has been started to gain more importance that using drug via inhalation in the therapy of respiratory diseases. But properties of drug and instrument used have determined effectiveness of the therapy. On the other hand it has been introduced a new problems that not encountered with other therapeutic models. So, a questionaire study evaluated knowledge and behaviour of chest physicians and residents in the our country was performed. It was asked for that 121 physicians, including 65 specialist (53.7%) and 56 resident (46.3%), to answer a questionaire form including 16 questions. Derivated results were evaluated by SPSS for Windows, an statistical program. It was determined that the most drugs used via inhalation were bronchodilators (84%) and the most way preferred was dry powder inhaler (55%). The majority of physicians answered the questionaire (74.8%) were recommending nebuliser treatment to their patients at home in the ratio of 5-10%. The physicians were preferring to use jet nebulisers at homa (99.1%) and hospital (54.7%). They were deciding to use nebuliser according to discordance to other treatments, not to see any benefit with other treatment, and requirement for high dose drug using. In choosing instrument, number of particle produced, number of respirable particles, and patient's accordance were being taken into cosideration. In determination of device's effectiveness, functional parameters such as forced expiratory volume in one second and peak expiratory flow rate were being used as a current criterion.

Özet

Son yıllarda inhalasyon yoluyla ilaç kullanmak, solunum hastalıklarının tedavisinde giderek daha fazla önem kazanmaya başlamıştır. Ancak kullanılan ilaç ve cihazın özellikleri tedavi etkinliğini belirlemektedir. Öte yandan diğer tedavilerle yaşanmayan bazı sorunları da gündeme getirmektedir. Bu nedenle ülkemizdeki Göğüs Hastalıkları uzmanları ve asistan doktorların bilgi ve tutumlarını değerlendiren bir anket çalışması yapıldı. 65'i uzman (%53.7), 56'sı (%46.3) asistan doktor olmak üzere 121 hekimin 16 sorudan oluşan bir anket formunu yanıtlamaları istendi. Elde edilen sonuçlar SPSS istatistik programı ile değerlendirildi. Buna göre inhalasyon yoluyla en sık kullanılan ilaç bronkodilatörler (%84), en sık kullanılan teknik kuru toz inhaler (%55) olarak belirlendi. Anketi yanıtlayan hekimlerin büyük bir çoğunluğu (%74.8) hastalarına ancak %5-10 oranında evde nebülizatör tedaviyi öneriyordu. Hekimler evde (%99.1) ve hastanede (%54.7) daha çok jet nebülizatör kullanmayı tercih ediyorlar. Nebülizatör kullanma kararlarını, diğer tedavilere uyumsuzluk, diğer tedavilerle yarar görememe ve yüksek doz ilaç kullanımı ihtiyacına göre veriyorlardı. Cihaz seçiminde oluşturulan partikül sayısı, solunabilen partikül sayısı ve hastanın koordinasyonu dikkate alınıyordu. Cihazın etkinliğini belirlemede en geçerli ölçüt olarak FEV1 ve PEF ölçümü gibi fonksiyonel parametreleri kullanıyorlardı.

🔖

Cite This Article

MİRİCİ, A., AKGÜN, M. (2000). A questionnaire study investigating the knowledge and behaviour by physicians about use of nebuliser. Toraks Dergisi, Cilt: 1 - Sayı: 1, 67–71. https://ajindex.com/articles/368037

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Nikander K. Some technical, physicochemical and physiological aspects of nebulization of drugs. Eur Respir Rev 1997;44:168-72
  2. Muers MF, Corris PA. Current best practice for nebuliser treatment. The nebuliser Project Group of the British Thoracic Society Standards of Care Committee. Thorax 1997;52(suppl.2):S3-S23
  3. Muers MF. The rational use of nebulisers in clinical practice. Eur Respir Rev 1997;44:189-97
  4. Kıter G, Sevinç Ç, Çımrın AH. Farklı inhaler tekniklerine hasta uyumları. Tüberküloz ve Toraks 1999;47:278-83
  5. Hutchinson GR et al. Home-use nebulisers; a potential primary source of Burkholderia Cepacia and other colistin-resistant gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol 1996;34:584-7. [ Özet ] [ Benzer Makaleler ] 6) Ball P. Epidemiology and Treatment of Chronic Bronchitis and its exarcerbations. Chest 1995;108:43-52
  6. Poundsford JC. Nebulisers for the elderly. Thorax 1997;52:53-5s.8. Smith EC, Kendrick AH, Brewin A. Staff Education. Thorax 1997;52:102-3. [ Özet ] [ Benzer Makaleler ] 9) Wilson RSE, Muers MF. Running a domicilary nebuliser service. Thorax 1997;52;2-S;104-5
  7. Caldwell NA, Milroy R, Mc Cabe J, et al. An audit of nebulization technique in a major teaching hospital: score for improvement. Pharm J 1991;247:706-8
  8. Graig IR, Riley MR, Cooke NJ. Prescribing of nebulized bronchodilators can we change bad habits? Respir Med 1989;83:333-4. [ Özet ] [ Benzer Makaleler ] 12) Hosker HSR, Teale C, Greenstone MA, Muers MF. Assesment of provision of home nebulizers for chronic obstructive pulmonary disease in the Yorkshire region of the UK. Respir Med 1994;89:47-52
  9. Vermeire P. European trends in the inhalation therapy. Eur Resp Rev 1994;4 (Suppl 18):89-91
  10. Muers MF. Overview of nebuliser treatment. Thorax 1997;52 (Suppl 2):31-44.